Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation

BACKGROUND: The optimal timing of initiating oral anticoagulants after reperfusion therapy for ischemic stroke is unknown. Factors related to early initiation of rivaroxaban and differences in clinical outcomes of stroke patients with nonvalvular atrial fibrillation (NVAF) who underwent reperfusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Koge, Junpei, Yamagami, Hiroshi, Toyoda, Kazunori, Yasaka, Masahiro, Hirano, Teruyuki, Hamasaki, Toshimitsu, Nagao, Takehiko, Yoshimura, Shinichi, Fujishige, Masahito, Tempaku, Akira, Uchiyama, Shinichiro, Mori, Etsuro, Koga, Masatoshi, Minematsu, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985957/
https://www.ncbi.nlm.nih.gov/pubmed/35385480
http://dx.doi.org/10.1371/journal.pone.0264760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985957/
https://www.ncbi.nlm.nih.gov/pubmed/35385480
http://dx.doi.org/10.1371/journal.pone.0264760

Ejemplares similares